Upadacitinib for the treatment of atopic dermatitis in the elderly: an Italian case series of seven patients

Figures & data

Table 1. Demographic and clinical characteristics of patients.

Age in years, median [range]	72 [66 – 75]
Body mass index, median [range]	23.78 [22.66 − 27.69]
Age at onset of disease in years, median [range]	65 [60 – 69]
Duration of disease in years, median [range]	6 [4 – 10]
Male sex, n	4
Areas of disease manifestation, n
Face/neck	5
Hands	3
Genital	2
Baseline cardiometabolic comorbidities, n
Arterial hypertension	3
Type two diabetes	1
Hypercholesterolemia	1
Cardiovascular disease	0
Atopic dermatitis phenotype, n
Flexural dermatitis	5
Generalized inflammatory	1
Eczema prurigo Nodularis-like	1
Previous exposure to Cyclosporine or contraindications	7
Previous exposure to Dupilumab	7

Figure 1. Eczema Area and Severity Index (EASI) Variation during follow-up observation. Seven patients reached week 32, four patients reached week 52 and three patients reached week 104.

Data availability statement

Data is available on request from the authors.